Navigation Links
GenVec Reports Fourth Quarter and 2010 Year-End Financial Results
Date:3/10/2011

GAITHERSBURG, Md.,  March 10, 2011 /PRNewswire/ -- Today GenVec, Inc. (Nasdaq: GNVC) announced financial results for the fourth quarter and year ended December 31, 2010.  For the year ended December 31, 2010, the Company reported a net loss of $12.3 million, or $0.10 per share, compared with a net loss of $18.4 million, or $0.19 per share, for the year ended December 31, 2009. GenVec ended the year with $35.2 million in cash, cash equivalents, and short-term investments.  

"In 2010 we made significant progress in our partnership with Novartis and our vaccine programs. We have significantly reduced our burn rate, and we are focused on executing a sustainable business strategy of using our differentiated, proprietary technology to create superior therapeutics and vaccines that are developed and commercialized through collaborations," stated Paul H. Fischer, Ph.D., GenVec's President and CEO.

2010 and Recent Corporate Highlights THERAPEUTIC PROGRAMS

  • We entered into a research collaboration and license agreement with Novartis to discover and develop novel treatments for hearing loss and balance disorders. In exchange for the world-wide rights to our preclinical hearing loss and balance disorders program, we received a $5.0 million upfront payment and Novartis purchased $2.0 million in GenVec common stock. If certain clinical, regulatory, and sales milestones were met, we were eligible, at the inception of the agreement, to receive up to an additional $206.6 million in milestone payments in addition to royalties on future sales.

  • We entered into an additional agreement with Novartis for development services relating to the companies' collaboration. Under this additional agreement, GenVec could receive approximately $13 million over four years to manufacture clinical trial material for up to two lead candidates, of which we recognized $
    '/>"/>

  • SOURCE GenVec, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. GenVec Forms Collaboration With World-Leading Animal Health Company
    2. GenVec Reports Third Quarter 2010 Financial Results
    3. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
    4. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
    5. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
    6. Transgenomic Reports Fourth Quarter Financial Results
    7. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
    8. Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS Elevate Anterior and Apical Prolapse Repair System
    9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
    10. Cardiogenesis Reports Fourth Quarter and Full Year 2010 Results
    11. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... 2014  RFID Journal announced today that registration is now ... the premier industry event focused on the use of ... The conference and exhibition will be held on Nov. ... Chicago, Ill. RFID ... how they use RFID to improve asset-utilization rates, reduce ...
    (Date:9/30/2014)... Sept. 30, 2014 It is evident from the ... is not performing upto expectations due to the lack of ... with the intake of omega-3 fatty acids. Among omega-3 ingredient ... fish oil, attributed to the large vegetarian population in ... polyunsaturated fatty acid (PUFAs) ingredients is in growth stage of ...
    (Date:9/30/2014)... , September 30, 2014 ... reagents is undergoing earthshaking changes. The country,s new leaders ... of in-vitro diagnostic reagents are far from perfect along ... past 30 years. Chinese state council issued the latest ... on February 12, 2014, and it has come into ...
    Breaking Medicine Technology:Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 2Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 3Omega-3 Polyunsaturated Fatty Acids (PUFAs) - An Indian Market Overview 2Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 5
    (Date:9/30/2014)... Healthpointe is proud to announce that ... and ankle reconstruction surgeries to assist patients with severe ... specializes in the diagnosis and treatment of sports medicine, ... also trained to perform advanced Foot and Ankle Reconstruction ... is also fluent in Spanish. , Reconstructive surgical procedures ...
    (Date:9/30/2014)... TX (PRWEB) September 30, 2014 ... Industry, 2009-2019 is a professional and in-depth market ... report firstly reviews the basic information of Cialis ... report then explores global and China’s top manufacturers ... value, and market share etc. , The report ...
    (Date:9/30/2014)... (PRWEB) September 30, 2014 To mark ... Editorial Board of Living with a Disability magazine ... light on hematological disorders as disabling conditions. ... more than a diagnosis to establish a disability related ... thrombocytomenia, myelofibrosis, hereditary telangiectasia, coagulation defects, polycythemia vera, and ...
    (Date:9/30/2014)... Catalent Pharma Solutions (Stand 2C9), ... and development solutions for drugs, biologics and consumer ... the 25th Annual CPhI Worldwide Exhibition to be ... 9th. , Catalent is showcasing a number of ... show, including its facilities in China and Japan, ...
    (Date:9/30/2014)... Jiwa Law Corporation, a personal injury law firm in Vancouver, ... free consultation for personal injury claims of their clients. This ... first time to meet the Vancouver ICBC lawyers will not ... what their rights are. The experts at Jiwa Law Corporation ... them what the law firm can do regarding their claim. ...
    Breaking Medicine News(10 mins):Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 3Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3Health News:Jiwa Law Corporation Now Offers Personal Injury Consultation Without Any Charge 2
    ... Journal of the American Heart Association, had said that ... risk of heart attacks and developing heart disease than ... blood pressure remaining between 120 and 139, and the ... Blood pressure hovering in any one of these two ...
    ... the link between alcohol and certain type of cancers, ... DNA repair pathways. ,The study examined the reaction ... induce cancer formation, found in alcohol) with polyamines - ... usually considered to be beneficial to the body because ...
    ... Latest research shows that drinking coffee could decrease the ... two cohort studies that showed self-reported frequency of coffee ... adjustment for potential confounders, researchers say they found that ... almost 30 per cent, while those drinking one or ...
    ... A new innovative vaccine for flu is under pre-clinical phase ... protection against flu. //, ,Flu is caused by virus ... virus. . Flu is an extremely contagious condition and makes ... serious consequences: According to the World Health Organization, on average ...
    ... are working on using virtual reality to help patients ... ,In this research, scientists are creating simulating virtual realities ... through the similar experiences they had felt when they ... had left them unable to cope reality. Called exposure ...
    ... Wales may be one of the first scientists to develop ... is no single test that could exactly identify the disease.//, ... latest issue of the journal Psychiatry Research said that this ... effective as their tool can safely distinguish between the two ...
    Cached Medicine News:Health News:Risk Of Heart Attack Increase From Pre-Hypertension 2Health News:New Flu Vaccine Can Give Lifetime Protection 2Health News:Schizophrenia Gets A New Diagnostic Tool 2
    Polyester ribbon impregnated with conjugated Protein G - .13 OD per sq. cm....
    Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
    ... glass (1.5x) Gonio lens will enable visualization ... 4 mirror lens is the industry preferred ... and features : , Crispest, clearest ... previously unattainable with Gonio lenses., 4 equally ...
    Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
    Medicine Products: